Trial Identifier: | PT003003 |
Sponsor: | Pearl Therapeutics, Inc. |
NCTID:: | NCT01349803 |
Start Date: | May 2011 |
Primary Completion Date: | November 2011 |
Condition: | Chronic Obstructive Pulmonary Disease (COPD) |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
Australia, New South Wales | Glebe, New South Wales, Australia |
Australia, Queensland | Caboolture, Queensland, Australia |
Australia, South Australia | Dawpark, South Australia, Australia |
Australia, South Australia | Toorak Gardens, South Australia, Australia |
Australia, Victoria | Heidelberg, Victoria, Australia |
Australia, Western Australia | Nedlands, Western Australia, Australia |
New Zealand, Dunedin | Caversham, Dunedin, New Zealand |
New Zealand, Hamilton | Private Bag, Hamilton, New Zealand |
New Zealand, North Island | Tauranga, North Island, New Zealand |
New Zealand, Wellington | Newtown, Wellington, New Zealand |
USA, Arizona | Glendale, Arizona, USA |
USA, California | Fullerton, California, USA |
USA, California | Los Angeles, California, USA |
USA, California | San Diego, California, USA |
USA, Florida | Pensacola, Florida, USA |
USA, Louisiana | Lafayette, Louisiana, USA |
USA, Massachusetts | North Dartmouth, Massachusetts, USA |
USA, Michigan | Livonia, Michigan, USA |
USA, Oregon | Medford, Oregon, USA |
USA, Texas | San Antonio, Texas, USA |